Product Description:

• 
  

  RUZURGI is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.

  
  

How to use:

• 
  

  Patients 6 to less than 17 years of age weighing 45 kg or more:

  
  
  
  
  • Initial dosage is 15 mg to 30 mg daily, in pided doses
  
  
  • Increase daily in 5 mg to 10 mg increments, pided in up to 5 doses daily
  
  
  • Maximum single dose is 30 mg; maximum daily dosage is 100 mg
  
  
  
  

Caution & Warnings:

• History of seizures


• Hypersensitivity to amifampridine or other aminopyridine

Side Effects:

• Paresthesia/dysesthesia, abdominal pain, dyspepsia, dizziness, and nausea.

Ingredients:

• Amifampridine 10Mg.